The whole MJ sector is way down today. Still, AEGY and SKTO seem to be awfully sluggish and slow with news.
SKTO has a product and some credibility, so I'm holding. They need to come out with the new ticker asap though.
I think that's a great idea, and good for everyone.
At this point though, Dr James Andrews is on board with SVFC. There can be no doubt whatsoever that with his foundation involved there is potential here. Andrews already has ALL of MLB coming to him. He wouldn't get involved if this were a scam.
This is a lottery ticket to hold onto. Not a trade. Waiting for patents and commercialization. If you want to trade, go to MJ stocks, VOIS.
Long - SVFC, QUTR, MCIG.
Once the merger comes thru, all this will be academic. I have faith in SKTO, and since they are bigger, I don't think most of the ad dollars will be going to pothead advertising.
SKTO is a serious company, and has been discussed positively in public by Gavin Newsome. Nuff said. AEGY has a web site to leverage. The only issue is if the merger falls thru. That seems unlikely as both are small companies with small prices, egos and footprint.
Agreed. If SWRL buys out Orange Leaf and starts to challenge yogurtland and yo fruz, SWRL could double or triple once the summer months hit.
I'm in the yogurt biz. If U SWRL is serious, and will spend thru RMCF to get to 500 stores it could become a real force in self serve fro yo.
I think that any consolidation in this industry is positive.
I like SKTO and their dharmanol because it's a real product that will provide real comfort for patients.
At this price you're buying shares of SKTO for almost nothing. They have a product, revenues, and backing in Northern Calif. This is as good a speculative play as any right now in MJ.
LONG - AEGY MCIG VOIS QUTR
Sentiment: Strong Buy
I've tried to read thru what's on investor hub but still can't grasp it all. The stock has true believers - real gung ho which is always a concern.
However the CEO is very transparent, very responsive, saying he will do full reporting and financials, new CFO, and wants to uplist. Obviously we're talking $1 or more a share target. If this is legit though I would guess the company would be bought out.
Apparently the CEO and his atty - and I think I agree - that MYEC's process is fully protected on the back end. A lawsuit will probably settle this eventually unless PayPal or Square or maybe a bank buys out MYEC, for say 60 cents/share:
Question: You've stated your front end is generic and back end patented. New owner of stock in Myecheck . My only concern: Can your patent be 'tweeked' by larger company and used, or are the parameters of patent solid and ground breaking enough not to be stolen and used by others?
Answer: Thanks great question, patents can't be tweaked once granted but some can be circumvented by not infringing on any claim in the patent. My belief and that of my attorney is that you cannot create an electronic check without infringing on exclusive rights granted to me by the UD government
Great hatchet job for shorts in SA today. Pricing FB as though it were a 20 yr old manufacturer
or KO MMM or GM. A bit silly.
The author himself even showed that using a Graham formula, FB is still undervalued ! Apply any mature valuation to LNKD YELP AMZN NFLX and see what you get.
While MZ and these deals are always question marks, I don't think he'd be buying knowing earnings were down. Of course it's possible but I don't think the board or Sandberg would let him run amok.
Still long since Feb 2012. This is a reasonable pullback and a decent buying oppy. I'm far ahead, and still believe it will get to $100. The problem is that just as they said from the beginning - FB HQ is in noooo hurry to try and get there.
There is no evidence offered to suggest an earnings miss. This would seem to be a good buying oppy leading up to earnings.
Sentiment: Strong Buy
See prior posts.
No point in betting against any stock with a product that is perceived as valuable by both the NIH and BAT.
Could mean this is a quiet period before a big pump. Or it could be the beginning of the end.
No volume, no comments, few following the stock. This is obviously going to be a big gamble that will pay off big if the company plays it correctly.
Let's assume three scenarios betting a dollar to see if holding makes sense - their product works, doesn't work, gets mixed results.
If the program really :
WORKS - the stock will likely go up 10x. Probablilty ~ 15%. NET GAIN on dollar bet = $.50
WORKS SOMEWHAT - stock goes up 3x. Probability ~ 50%. NET GAIN on dollar bet = $.50
WORKS NOT AT ALL - stock collapses. Probability ~ 35%. NET GAIN on dollar bet = ($1.00).
I'm guessing the product works somewhat, perhaps a 4 out of 10 scale. At this price with no interest in the stock, it seems worth holding and still seeing what Windmill is going to do. Since this is a health care stock with a product that could codify clinical standards and control costs, even a partially positive result will skyrocket the stock.
It's a lottery ticket. I'm going to hold and wait since it's the stock is using a clinical program vetted by other NYC doctors with apparently good reputations. Very speculative buy.
I like AHII but some research uncovered that AHII was using a paid promoter. Just read about it in the last 48 hours and glad I dumped with a profit. Company may have a future, who knows. Right now it's a pump and dump.
MCIG has revenues, products, profits, and even a possible dividend. Most of the other pot stocks will likely be bought out or fail once big tobacco and regulation gets involved.
MCIG has the most going for it right now. It's the best ecig/pot stock imho. I'm not an expert. The others don't report, have no transparency, no product, and seem to have shady leadership and iffy balance sheets.
MCIG doesn't have the toxic debt or the shady business reporting. It's a penny stock that is clearly risky, but it's a good speculative buy. check out MYEC and SPLI. Interesting charts.
LONG - MCIG SPLI MYEC GLLA QUTR.
If the NIH is ordering the product, there is a reason. The hoops you have to jump thru to get an NIH order for research are unreal.
The product and the business are hard to grasp and subject to the usual hyperbole from anti smoking MJ and vaping groups. The difference here is that the goal is to get people off tobacco by getting them off nicotine. That's all.
I'm an MD, MPH, MBA. If the company were trying to promote the product outside of the NIH research channels I wouldn't invest. This sell off may be in reaction to the "horrible" dangers of liquid nicotine. lol. Meanwhile liquid alcohol alone causes 10000 times as many deaths every year than liquid nicotine, ecigs or MJ. It's a fact. Look it up. Go to fox, huff, or Bloomberg. Facts are facts.
LONG - GLLA XXII MCIG SPLI VOIS QUTR
Sentiment: Strong Buy
lol.... well obviously the AH traders don't quite seem to be disagreeing with my analysis.
and cutting losses on a stock that has a $9 target and patents licensed by multibillion dollar companies doesn't make much sens.
Anyway I bought more at the sell off, and I'm glad I did.
Sentiment: Strong Buy
I'm a public health physician, and this angle is preposterous and silly. Inhaling Nicotine is no worse than having a few drinks everyday. XXII has a good product to be used in a good way. If this article is causing the panic it's moronic.
People want to use nicotine, alcohol, caffeine and other substances. Always have, always will. Liquid nicotine is so much safer than smoking tobacco it's like the difference between mainlining heroin, and having a beer.
Pure nicotine poisoning is so rare it's one of the rarest causes of death in the world. Meanwhile 2nd hand tobacco smoke is hurting kids and adults every day.
The point is that tobacco cigarette smoking causes harm, and the new industries such as e cigs, vaping and XXII products are directly aimed at reducing that harm. Get real everyone. I'm going to hold this and buy more.
This sell off is silly. There is ZERO evidence that XXII is directly contributing to new smokers or cancer or anything harmful. WHY ELSE WOULD THE NIH USE, ORDER AND STUDY THEIR PRODUCT ? For now, I'll hold. I know of NO anecdotal or clinical evidence that XXII products are directly promoting smoking. If they were, I wouldn't invest. I'm an MD, MPH and worked for a local health department many yrs.
Sentiment: Strong Buy
Was there some sort of article in MSM or NY Times this week? If so, post please.
XXII produces a completely necessary legal product that is going to be used by NIH to study ways to get smokers to quit. It's complicated and not surprising that there would be a sell off or a misinterpretation one day about its ethos.
With a government contract in place, this sell off would really appear to be a function of PR knee jerk reaction to some sort of attack piece. Anyone found an article?
Sentiment: Strong Buy
Well it looks like this a gamble that might just pay off. Some CEOs do sound a bit more legit than others.
This one seems to truly believe in the future of his company. If MYEC somehow manages to become the premier method for MNJA payment in California, the stock price could be 1000x over in less than a year.
Holding for a bumpy road that might pay off. If it progresses, MYEC might be bought out by PayPal or V someday. You never know. This penny is clearly worth a gamble now.
I guess since the stock has already moved up over 800% over the past yr it does need a breather, along with the usual MM manipulation.
The most important thing about the company right now is that they claim they will be fully reporting, fully audited, and are actively seeking to uplist. Without those publicly declared intents, this is just another lottery penny stock.
The CEO sounds credible but this still sounds like a development stage company that is understaffed and overwhelmed with its fast stock price growth. Elon Musk got fabulously wealthy off PayPal, and anything that can compete with ACH or Paypal is worth a look.
I think this is just a lull with profit taking and the chill and no news. The potential is vast, and the CEO is saying the right things. They just hired a real CFO, so it's clear that we are talking about a very new, very young development stage company. If you have faith in the CEO - and the guy seems like he's trying desperately to do what's good for shareholders - this penny seems worth the risk to start a position.
Accumulation has been steady until recent profit taking. When it drops to a .0125 I think it will go back to being a strong buy. I'm no penny expert, but I'm going to hold because they are willing to be audited and we should hear the results in a couple of weeks. Maybe that DTC will lift once all this auditing is thru. MYEC seems worth the gamble here.
LONG - MCIG SPLI GLLA AHII VOIS QUTR SVFC MYEC
Interesting idea. Haven't heard anything but It will probably take some consolidation of the industry to fend off big tobacco.
MCIG is near Seattle, while SPLI is based on FLA. MCIG seems to be reporting next wk and if they do well, they probably have at least another year without having to be bought up.
Perhaps VAPE ECIG MCIG SPLI might form a single entity someday or will be bought out by NJOY. That may be the best way they can compete if big tobacco gets involved.
Either way, these stocks are the first movers and whichever survive or is bought up could be 10 baggers in the next 2 years. MCIG SPLI ECIG all have a shot.